Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
Trump Says Anthropic No Longer Seen as National Security Threat 
Alibaba Group (NYSE:BABA; HK:9988) saw its shares decline on Friday following the announcement of a HK$12 billion ($1.53 billion) zero-coupon exchangeable bond offering tied to its healthcare subsidiary, Alibaba Health Information Technology (HK:0241).
Unveiled on Thursday and priced on Friday, the bonds are exchangeable into Alibaba Health shares at a 48% premium to the company’s recent private placement price of HK$6.23. Investors can convert the bonds into shares beginning on the 41st day after issuance, with a maturity set for 2032.
The move comes as part of Alibaba’s strategy to boost investment in cloud computing infrastructure and global e-commerce operations, areas the tech giant has prioritized amid rising competition in the sector. The offering marks Alibaba’s second significant bond issuance within a year, following a $5 billion dual-currency deal in late 2024.
While the bond deal may support Alibaba’s long-term strategic goals, investors reacted cautiously. Alibaba Group’s Hong Kong-listed shares dropped as much as 3% on Friday, and Alibaba Health shares declined nearly 7%, reflecting concerns over potential equity dilution and market volatility.
This bond issuance underscores Alibaba’s ongoing effort to unlock value from its subsidiaries and raise capital for expansion, even as market sentiment remains sensitive to large-scale financial maneuvers. The company continues to navigate a complex landscape of regulatory shifts, global economic uncertainty, and evolving consumer behavior in both domestic and international markets.
By leveraging Alibaba Health’s equity through premium-linked bonds, the company aims to balance capital efficiency with investor flexibility—though short-term market reactions suggest cautious optimism at best.
